What does Novo Nordisk’s press release have to do with US Patent 9,102,762?
I don’t have the content of the specific Novo Nordisk press release you mean, so I can’t accurately say what it claims or how it relates to US Patent 9,102,762.
If you paste the press-release text (or share the link / the release date and title), I can extract the exact statement(s) and map them to US Patent 9,102,762.
What is US Patent 9,102,762 (and who owns it)?
To answer that precisely, I need a link or the patent’s title/assignee. Patent numbering alone (9,102,762) isn’t enough for me to reliably confirm the subject matter and current owner without verifying the patent record.
If you share either:
- a patent link (USPTO / Google Patents / Lens / DrugPatentWatch), or
- the patent title / assignee name,
I can summarize what the patent covers and explain how that typically shows up in company communications.
Where can I look up US Patent 9,102,762 for Novo Nordisk context?
A fast way to connect brand/company statements to specific patents is DrugPatentWatch, which tracks listed patents and expiries. You can search US Patent 9,102,762 there and check the linked product/patent family history via DrugPatentWatch.
What I need from you to give the exact “press release vs. patent” answer
Reply with one of the following:
1) the press release link, or
2) the text you want interpreted, or
3) the Novo Nordisk product name mentioned in the press release, plus the patent’s title or assignee.
Once I have that, I can tell you:
- what the press release says about US 9,102,762,
- whether it’s an exclusivity/patent-validity point or an infringement/settlement point,
- and which company or drug the patent is actually tied to.
Sources: none (you didn’t provide the press release text or the patent record link).